Overview

• The agency’s fourth survey reports more than 4,000 cases across the EU/EEA since 2013, including a record 1,346 cases in 2023 reported by 18 countries.
• Recent outbreaks were identified in Cyprus, France and Germany, while Greece, Italy, Romania and Spain report such widespread transmission that individual outbreaks can no longer be distinguished.
• Only 17 of 36 countries have national surveillance and just 15 have dedicated infection‑prevention guidance, raising the likelihood of under‑reported cases.
• C. auris often resists frontline antifungals, persists on hospital surfaces and equipment, and has been linked to high mortality in vulnerable patients, with reports citing rates up to about 60%.
• ECDC says early case finding with rapid, coordinated infection control can curb spread, as funding data show uneven support for new antifungals following a 2022 surge to about US$383 million and no new commitments reported in 2025.